Organon & Co | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Celltrion KRW 829.07B 829.07B 2025-03
Cspc Pharmaceutical 6.78B 1.6B 2024-12
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Gilead Sciences USD 5.14B 2.78B 2025-06
Glaxosmithkline GBP 3.87B 678M 2024-12
Kangmei Pharma CNY 894.14M 120.63M 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.62M 7.88M 2024-12
Merck USD 8.01B 622M 2025-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Novartis USD 11.46B 2.15B 2024-12
Organon & Co USD 599M 52M 2025-06
Pharma Mar EUR 21.59M 38.7M 2025-06
Qiagen NV USD 733.82M 95.06M 2025-06
Sartorius EUR 819M 20.5M 2025-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 189.7M 15.49M 2024-11


Organon & Co Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.